| Item Type | Name |
|
Concept
|
Death, Sudden, Cardiac
|
|
Academic Article
|
Impact of Advanced Therapies for Improving Survival to Heart Transplant in Patients with Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Syncope and risk of sudden death in hypertrophic cardiomyopathy.
|
|
Academic Article
|
There is No Reason to Adopt ECG s and Abandon American Heart Association/American College of Cardiology History and Physical Screening for Detection of Cardiovascular Disease in the Young.
|
|
Academic Article
|
Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Surviving malignant hypertrophic cardiomyopathy with all major complications in a single patient.
|
|
Academic Article
|
A novel patient-patient network medicine approach to refine hypertrophic cardiomyopathy subgrouping: implications for risk stratification.
|
|
Academic Article
|
After 60 Years Hypertrophic Cardiomyopathy is Finally Recognized as a Contemporary Treatable Disease With Low Mortality and Morbidity, But is This Paradigm Under-Recognized in the Literature?
|
|
Academic Article
|
Do Implantable Cardioverter-Defibrillators Really Belong on the Athlete Field?
|
|
Academic Article
|
Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Evidence That Subcutaneous Implantable Cardioverter-Defibrillators Are Effective and Reliable in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Re-examining family history of sudden death as a risk marker in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Reply: What Is the True Prevalence of Hypertrophic Cardiomyopathy?
|
|
Academic Article
|
Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
|
|
Academic Article
|
Global Burden of Hypertrophic?Cardiomyopathy.
|
|
Academic Article
|
My approach to clinical management of hypertrophic cardiomyopathy.
|
|
Academic Article
|
Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Medical and Legal Determinants of Sports Eligibility for Young Competitive Athletes With Cardiovascular Disease.
|
|
Academic Article
|
Editorial commentary: Hold your horses (and mice, rats, and cats): How relevant really are animal models of hypertrophic cardiomyopathy?
|
|
Academic Article
|
How to Image Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Hypertrophic cardiomyopathy.
|
|
Academic Article
|
Relation of pulse pressure to blood pressure response to exercise in patients with hypertrophic cardiomyopathy.
|
|
Academic Article
|
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
|
|
Academic Article
|
The role of cardiovascular magnetic resonance in sudden death risk stratification in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Hypertrophic Cardiomyopathy and Sudden Death Initially Identified at Autopsy.
|
|
Academic Article
|
Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
The Guidant Affair revisited?but this time with good news.
|
|
Academic Article
|
Cats Have Nine Lives but This Hypertrophic Cardiomyopathy Patient Has Had Ten (So Far).
|
|
Academic Article
|
Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective.
|
|
Academic Article
|
Characteristics of Patients With Obstructive Hypertrophic Cardiomyopathy in Real-World Community-Based Cardiovascular Practices.
|
|
Academic Article
|
Risk Stratification in Hypertrophic Cardiomyopathy: Highly Effective, But Could It Be Better?
|
|
Academic Article
|
Hypertrophic Cardiomyopathy in?Adulthood Associated With Low?Cardiovascular Mortality With Contemporary Management Strategies.
|
|
Academic Article
|
Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors.
|
|
Academic Article
|
Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?
|
|
Academic Article
|
Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Hypertrophic Cardiomyopathy: Is a 'Cure' Coming . . . Or Is It Already Here?
|
|
Academic Article
|
New perspectives on the prevalence of hypertrophic cardiomyopathy.
|
|
Academic Article
|
Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
|
|
Academic Article
|
Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy.
|
|
Academic Article
|
Identification of high-risk imaging features in hypertrophic cardiomyopathy using electrocardiography: A deep-learning approach.
|
|
Academic Article
|
Differing strategies for sudden death prevention in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management.
|
|
Academic Article
|
Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.
|
|
Academic Article
|
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
|
|
Academic Article
|
Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Back to the future: Predicting sudden death in hypertrophic cardiomyopathy relying on individual risk markers and physician judgment without mathematical scoring.
|
|
Academic Article
|
Structurally Normal Hearts Are Uncommonly Associated With Sudden Deaths in Athletes and Young People.
|
|
Academic Article
|
Is It Fair to Screen Only Competitive Athletes for Sudden Death Risk, or Is It Time to Level the Playing Field?
|
|
Academic Article
|
Shared decision-making in HCM.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
J Point Elevation in Hypertrophic?Cardiomyopathy: Riding a New Wave in Risk Stratification?
|
|
Academic Article
|
Sports and arrhythmias: a report of the International Workshop Venice Arrhythmias 2009.
|
|
Academic Article
|
Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study.
|
|
Academic Article
|
What Do Patients With Hypertrophic Cardiomyopathy Die from?
|
|
Academic Article
|
Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices.
|
|
Academic Article
|
Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator.
|
|
Academic Article
|
Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
|
|
Academic Article
|
Concerns About the HCM Risk-Kids Study.
|
|
Academic Article
|
The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023.
|
|
Academic Article
|
Family History of Sudden Death Should Be a Primary Indication for Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
|
|
Academic Article
|
Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Risks of the Athletic Field Revisited: Report of Unusual Occurrences of Cardiac Arrest and Sudden Death in Professional Soccer Players.
|
|
Academic Article
|
Asymptomatic young man with Danon disease.
|
|
Academic Article
|
Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants.
|
|
Academic Article
|
Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.
|
|
Academic Article
|
Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.
|
|
Academic Article
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
|
|
Academic Article
|
Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
|
|
Academic Article
|
Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy: A Multicenter Cohort Study.
|
|
Academic Article
|
Letter by Maron et al Regarding Article, "Sudden Cardiac Death in National Collegiate Athletic Association Athletes".
|